MODULE 3: Epilepsy Support and Non-medication Management 22 References 1. Perucca E, Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol. 2011;10(5):446–456. 2. Lu B, Elliott JO. Beyond seizures and medications: normal activity limitations, social support, and mental health in epilepsy. Epilepsia. 2012;53(2):e25–e28. 3. Sander JW. Ultimate success in epilepsy–the patient's perspective. Eur J Neurol. 2005;12(Suppl 4):3–11. 4. Caraveo N, Chen S, Evrard C, Ozuna J; Epilepsy Centers of Excellence Nursing Workgroup. Self-management in Epilepsy. A Guide for Healthcare Professionals. Washington DC: US Department of Veterans Affairs; 2015. Available at http://www.epilepsy.va.gov/Library/Self-Management%20In%20Epilepsy.pdf. 5. Epilepsy Action. Safety Advice for People With Epilepsy. https://www.epilepsy.org.uk/info/safety. Published 2016. 6. England MJ, Liverman CT, Schultz AM, Strawbridge LM, eds. Epilepsy Across the Spectrum. Promoting Health and Understanding. Washington, DC: Institute of Medicine of the National Academies. The National Academies Press; 2012. 7. Centers for Disease Control and Prevention. Living Well With Epilepsy. Available at http://www.cdc.gov/epilepsy/ pdfs/epilepsy-brochure-508.pdf. 8. Agency for Healthcare Research and Quality. Self-Management Support. http://www.ahrq.gov/professionals/ prevention-chronic-care/improve/self-mgmt/index.html. Published 2015. 9. Hixson JD, Barnes D, Parko K, et al. Patients optimizing epilepsy management via an online community: the POEM Study. Neurology. 2015;85(2):129–136. 10. Epilepsy Foundation. Triggers of Seizures. http://www.epilepsy.com/learn/triggers-seizures. March 2014. 11. Epilepsy Foundation. What Are the Risk Factors? http://www.epilepsy.com/learn/epilepsy-101/what-are-risk-factors. March 2014. 12. Epilepsy Foundation. What Happens During a Seizure. http://www.epilepsy.com/learn/epilepsy-101/what-happens- during-seizure. March 2014. 13. Boggs JG. Simple Partial Seizures. Medscape. http://emedicine.medscape.com/article/1184384-overview?pa=2LkI4 3pUJ9qhbNCmbvH6dC9VbFUt%2Bfsgd6maGfrtZu4STfKIW7jYut R7VSeJY4n28SIvl8zjYv73GUyW5rsbWA%3D%3D. February 2016. 14. Fisher RS, Cross JH, French JA, et al. Operational Classification of Seizure Types by the International League Against Epilepsy. International League Against Epilepsy: 2016. http://www.ilae.org/visitors/centre/documents/ ClassificationSeizureILAE-2016.pdf. 15. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–1077. 16. Brown C. Pharmacological management of epilepsy. Prog Neurol Psychiatry. 2016;March/April:27–34c. 17. Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus – Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515–1523. 18. Collazo IVM, Tatum WO. Sudden unexpected death in epilepsy (SUDEP). Are all your patients informed? Neurologist. 2016;21(4):66–71. 19. Epilepsy Foundation SUDEP FAQ. Epilepsy Foundation. http://www.epilepsy.com/learn/impact/mortality/sudep/ sudep-faq. August 2013. 20. Epilepsy Foundation. Seizure Response Plans 101. http://www.epilepsy.com/get-help/managing-your-epilepsy/ seizure-response-plans-101. August 2013. 21. Epilepsy Foundation of Michigan. Community Education. http://www.epilepsymichigan.org/page.php?id=334. 22. Kerr MP. The impact of epilepsy on patient’s lives. Acta Neurol Scand. 2012;126(Suppl 194):1–9. 23. Tang V, Poon WS, Kwan P. Mindfulness-based therapy for drug-resistant epilepsy: an assessor-blinded randomized trial. Neurology. 2015;85(13):1100–1107.